NCBiotech News

Morrisville-based airway products company Circassia is breathing a sigh of relief over a decision by the giant AETNA health insurance company that the NIOX, one of Circassia’s key asthma products, is “medically necessary.

Mispro Biotech Services, a Quebec-based preclinical services company offering research animal vivarium space and support services for life science investigators, has completed a major renovation of its multi-user facility in Research Triangle Park.

Boston-based Indigo Agriculture, which has an expanding facility in Research Triangle Park, has launched an online grain sales platform called MarketPlace that is supported by the closing of a $250 million Series E round of financing.

Precision BioSciences, a Durham-based genome editing company, has formed a strategic collaboration potentially worth more than $445 million with global biopharmaceutical company Gilead Sciences, to develop new therapies aimed at curing hepatitis B infections.

Raleigh-based UVision360 has achieved a dual-indication clearance from the U.S. Food and Drug Administration for its all-in-one LUMINELLE DTx Hysteroscopy System to be used clinically for hysteroscopy and cystoscopy in women.

bluebird bio, a gene therapy company with operations in Durham, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration for Lenti-D, its potential treatment for a rare and life-threatening neurological disorder in boys.

North Carolina Central University will soon make it easier for area biopharmaceutical companies to fill job vacancies with qualified employees via online courses offered through NCCU’s Biomanufacturing Research Institute and Technology Enterprise (BRITE).

Grifols, a global biotherapeutics company with major operations in North Carolina, has received approval from the U.S. Food and Drug Administration for a new formulation of GamaSTAN, its medicine for treating patients who’ve been exposed to the hepatitis A or measles viruses.

Research Triangle Park-based CertriRx recently started doing business as Verinetics. But the young company hasn’t changed its focus, or the speed with which it is making inroads in anti-counterfeiting technology.

Ken Hoffman, a veteran of the clinical diagnostics industry, was living and working in Boston some 20 years ago when he chose to move his new startup company, Cygnus Technologies, to the small North Carolina coastal community of Southport to enjoy a different lifestyle. It led to big-time success and growth.

As algae blooms fed by chemical fertilizer runoff from farms and lawns contaminate more waterways every year, Mirimichi Green Express is rooting its future in high-end eco-sensitive plant-growing products in the Southeastern North Carolina community of Castle Hayne, near Wilmington.

As the co-founder, CEO and board chair of Javara Inc., a privately funded Winston-Salem clinical research services firm, Jennifer Byrne is convinced her company’s newly minted “Integrated Research Organization" platform offers a more-effective solution to the immense challenges of patient enrollment in clinical trials.

Durham-based 410 Medical, developer of a new medical device for treating critically ill patients, has raised $3.1 million in new financing to commercialize the product.

Professionals involved in the field of precision health have until September 14 to use a special discount code when registering to attend the September 24 and 25 Precision Medicine World Conference 2018 (PMWC) at Duke University’s Fuqua School of Business.

Aerie Pharmaceuticals, an ophthalmic pharmaceutical company based in Durham, has reported positive clinical results for Rhopressa, its once-daily eye drop approved for the reduction of elevated eye pressure, a cause of glaucoma.